Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

INTRODUCTION: Many patients with type 2 diabetes mellitus (T2DM) suffer from complications that impose substantial burdens on prognosis and medical costs. Accumulating evidence has demonstrated the clinical benefit of sodium–glucose cotransporter 2 inhibitors (SGLT2i) on cardiovascular and renal com...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Ataru, Maruyama-Sakurai, Keiko, Kubota, Anna, Akiyama, Hiroki, Yajima, Toshitaka, Kohsaka, Shun, Miyata, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240120/
https://www.ncbi.nlm.nih.gov/pubmed/35710646
http://dx.doi.org/10.1007/s13300-022-01270-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240120/
https://www.ncbi.nlm.nih.gov/pubmed/35710646
http://dx.doi.org/10.1007/s13300-022-01270-8

Ejemplares similares